The Times Australia
PR Newswire

.

Clinical Trial Industry Veteran Paul Malan Joins Bioforum as Vice President of Biostatistics

NESS ZIONA, Israel, April 21, 2021 /PRNewswire/ -- Bioforum[1], a data-focused contract research organization (CRO) serving life sciences organizations worldwide, today announced that Paul Malan has joined the company as Vice President of Biostatistics. In this new role, Malan will drive the global expansion of Bioforum's biostatistics capabilities as well as the company's functional service provider (FSP)[2] division, designed to provide flexible, scalable partnership support to clinical trial sponsors of all sizes, with a key focus on small-to-midsize life sciences organizations and innovative startups.

Malan, who brings more than 17 years of experience to Bioforum, will lead a global team responsible for the statistical aspects of planning and executing clinical trials, including study design, statistical analysis and reporting. He joins Bioforum from IQVIA, where he began his career as a statistician in 2003. Over the years, Malan held roles of increasing responsibility at IQVIA, moving up the ranks to serve as Country Manager for the IQVIA Biostatistics and Statistical Programmer groups in South Africa. In addition, Malan led a major FSP program for IQVIA, overseeing the work of more than 235 biostatisticians and statistical programmers dedicated to a large, multinational pharmaceutical company. 

"Paul's guidance will help ensure our success designing and executing innovative strategies for our clients' novel clinical trials, as we continue to expand in the US, Europe, Asia Pacific, South Africa and Israel," said Amir Malka, Bioforum's Co-Founder and President. "We feel fortunate to have Paul on board, working closely with sponsors, regulators and other stakeholders across the global ecosystem to maximize the success of vital research studies that have the potential to bring needed new therapies to patients." 

A member of the South African Statistical Association, Malan holds a master's degree in statistics from the University of the Free State in Bloemfontein, South Africa. He has extensive experience in phase I – IV clinical trials, mapping and implementing data standards established by the Clinical Data Interchange Standards Consortium (CDISC), and Good Clinical Practice (GCP) guidelines.

"It's a thrill to join Bioforum at this exciting growth stage and have the opportunity to contribute to enriching the company's unique value proposition," Malan added. "I'm honored to be working alongside such a skilled and passionate team as we build a world-class biometrics and data analytics organization that will leverage statistical knowledge and technology to provide quality expertise and services to our clients and partners around the world."

About Bioforum the Data Masters

Bioforum is a data-focused contract research organization (CRO), serving clients worldwide in optimizing the collection, standardization, and reporting of clinical research data. We strive to consistently improve and innovate data processes, enabling the most efficient data submissions for our clients across the life sciences industry worldwide. From our offices in Israel, the U.S., Australia, and South Africa, our multidisciplinary team provides in-depth expertise and delivers high-quality solutions, including medical writing, data management, statistical programming and biostatistics. To learn more about us and our services, visit bioforumgroup.com or find us on LinkedIn at linkedin.com/company/bioforum-ltd.[3][4][5][6][7][8]

Bioforum ContactTali Rahinsteintalir@bioforumgroup.com[9]

 

References

  1. ^ Bioforum (bioforumgroup.com)
  2. ^ functional service provider (FSP) (bioforumgroup.com)
  3. ^ medical writing (bioforumgroup.com)
  4. ^ data management (bioforumgroup.com)
  5. ^ statistical programming (bioforumgroup.com)
  6. ^ biostatistics (bioforumgroup.com)
  7. ^ bioforumgroup.com (bioforumgroup.com)
  8. ^ linkedin.com/company/bioforum-ltd. (www.linkedin.com)
  9. ^ talir@bioforumgroup.com (www.prnasia.com)

Read more https://www.prnasia.com/story/archive/3349361_AE49361_0

Business Times

Ricoh Launches IM C401F A4 Colour MFP to Boost Speed and Security…

Ricoh, a leading provider of smart workplace technology, today launched the RICOH IM C401F, an enterprise-grade A4 colour d...

Laundrlab Expands with a New Flagship Store, Redefining Sustainab…

DESIGNED TO CALM. BUILT TO LAST. POWERED BY PURPOSE. THE FUTURE OF LAUNDRY STARTS IN POTTS POINT Sydney, N...

Navigating Leadership Mistakes with Confidence

I am always surprised by this question: How do leaders get over embarrassing mistakes and still succeed? The use of the w...

The Times Features

Could we one day get vaccinated against the gastro bug norovirus? Here’s where scientists are at

Norovirus is the leading cause[1] of acute gastroenteritis outbreaks worldwide. It’s responsible for roughly one in every five cases[2] of gastro annually. Sometimes dubbed ...

Does running ruin your knees? And how old is too old to start?

You’ve probably heard that running is tough on your knees – and even that it can cause long-term damage. But is this true? Running is a relatively high-impact activity. Eve...

Jetstar announces first ever Brisbane to Rarotonga flights with launch fares from just $249^ one-way

Jetstar will start operating direct flights between Brisbane and Rarotonga, the stunning capital island of the Cook Islands, in May 2026, with launch sale fares available today...

Introducing the SE 2 and Mini hair dryers from Laifen

The Mane Attractions for Professional Styling at Home Without the Price Tag Fast, flawless hair is now possible with the launch of Laifen’s two professional quality hair dryers th...

Home Gym Recovery Routines: What Pro Athletes Do After Workouts

Training is only half the equation. What you do after your workout has just as much impact on your progress, performance, and long-term health. Professional athletes know this, w...

Flipping vs. Holding: Which Investment Strategy Is Right for You?

Are you wondering whether flipping a property or holding onto it is the better investment strategy? The answer isn’t one-size-fits-all. Both strategies have distinct advantages a...